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a b s t r a c t
Aims: The comparison of what physicians and patients consider important in being cured from
depression.
Methods: 426 outpatients (in primary care and in psychiatric care) with a clinical diagnosis of major
depressionwere included: at the start of antidepressant treatment, the importance of a range of items for
being cured from depression (depressive, anxious and somatic symptoms, positive affect, functional
impairment, quality of life) was assessed in physicians and patients separately and a ranking was made;
after 3 months of treatment, the importance of these items for being cured from depression was
re-assessed in the patients.
Results: The items ranked top 10 by physicians mainly contain depressive symptoms while those ranked
top 10 by patients mainly contain positive affect items and this attention to positive affect even increases
at 3 months follow-up and is higher in patients with recurrent depression than in patients with a ﬁrst
episode of depression. Somatic symptoms consistently get the lowest ranking, as well in physicians as in
patients.
Conclusions: Physicians differ signiﬁcantly from patients in what they consider important for ‘being cured
from depression’: physicians mainly focus on alleviation of depressive symptoms while patients mainly
focus on the restoration of positive affect.
& 2014 Published by Elsevier B.V.
1. Introduction
Changes in symptom severity during antidepressant treatment are
usually assessed with observer rating scales: the 17-item Hamilton
Depression Rating Scale (HDRS) or the 10-item Montgomery–Asberg
Depression Rating Scale (MADRS), hence giving priority to the
physician's view on change (Hamilton, 1960; Montgomery and
Asberg, 1979). The purpose of the HDRS was developing a scale for
assessing severity and change during treatment within a population of
patients already diagnosed with depression. It is interesting that the
purpose of the MADRS was sensitivity and accuracy of change dur-
ing antidepressant treatment: the authors chose the 10 items
(out of the 65 items of the CPRS – Comprehensive Psychiatric
Rating Scale) that changed most during treatment with a variety of
antidepressants with different mechanisms of action (mianserin,
amitriptyline, maprotiline and clomipramine) (Montgomery and
Asberg, 1979; Asberg et al., 1978). For the assessment of the efﬁcacy
of antidepressants, regulatory bodies consistently request one of these
2 standard observer-rating depression scales to be used and physi-
cians are trained to use them in clinical practice. It is important to
mention that both scales were published even before DSM-III was
introduced and the content of these scales hence does not fully
represent the currently used diagnostic criteria for depression
(American Psychiatric Association, 1980).
It is remarkable that the 2 core symptoms of the DSM diagnostic
criteria are to a different degree included in the rating scales, but
both symptoms do lose the ‘core symptom’ position they have in the
diagnostic criteria. While sad or depressed mood is well represented
in both scales, it is remarkable and/or problematic that anhedonia
has a very marginal position in both scales.
The 17-item HDRS indeed pays more attention to negative
affect items than to anhedonia: depressed mood (sadness, hope-
less, helpless, worthlessness…hence not only referring to affect
but also to cognitions), psychic anxiety (psychological: subjective
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tension and irritability, worrying) and somatic anxiety (Hamilton,
1960). Only one item is referring more or less to anhedonia: work
and activities (thoughts and feelings of incapacity, fatigue or
weakness, loss of interest in activities, hobbies or work, decrease
in actual time spend in activities or decrease in productivity,
stopping working…hence not only referring to anhedonia but also
to functioning).
The same is true for the 10-item MADRS containing 3 negative
affect items: apparent sadness (representing despondency, gloom
and despair, (more than just ordinary transient low spirits),
reported sadness (representing depressed mood, low spirits,
despondency or feeling of being beyond help without hope) and
inner tension (representing feelings of ill-deﬁned discomfort,
edginess, inner turmoil mounting to either panic, dread or
anguish) (Montgomery and Asberg, 1979). And only one item is
referring to anhedonia although in the higher scores it is referring
to complete inability to feel positive as well as negative emotion:
inability to feel (representing the subjective experience of reduced
interest in the surrounding, or activities that normally give
pleasure up to the experience of being emotionally paralyzed,
inable to feel anger, grief or pleasure).
Two remaining questions are whether observer-rating indeed
are superior to self-rating scales and whether the content of these
observer rating scales really reﬂect the concerns of patients about
outcome in depression treatment. It is known that discrepancies
can exist between observer- and self-rating scales: in comparison
to observer rating very severely depressed patients have been
shown to underrate the severity of their depression while mildly
depressed patients have been shown to overrate the severity of
their depression (Möller, 2000). Discrepancies also exist between
the content of the most frequently used rating scales and what
patients expect from treatment: Zimmerman showed that, from a
patient perspective, the rank order of the most important expecta-
tions from antidepressant treatment are ﬁrst presence of positive
mental health (optimism, vigor, self-conﬁdence), second feeling
like your usual, normal self, third return to usual level of
functioning at work, home or school, fourth feeling in emotional
control, ﬁfth participating in and enjoying relationships with
family and friends, and only sixth absence of symptoms of
depression (negative affect) (Zimmerman et al., 2013). They
developed the Remission from Depression Questionnaire (RDC),
a 41-item self-report measure that assesses an array of features
reported by patients as relevant to determining remission from
depression, including positive mood (Zimmerman et al., 2013).
Signiﬁcant differences were found for HDRS remitted patients
(observer rated) and RDQ remitted patients (self-rated) and
depressed patients were shown to have a perspective of remission
going beyond symptoms resolution and also including positive
mental health or life satisfaction. On the same lines, another group
developed the REMIT (Remission Evaluation and Mood Inventory
Tool) questionnaire taking into account patient expectations: in
predicting patient assessed recovery from depression, adding the
5 items of the scale (emotional control, contentedness, future
seeming dark, ability to bounce back and happiness) to the Patient
Health Questionnaire (PHQ, reﬂecting DSM criteria of depression)
yielded an 11% increase in R2 beyond the 60% yielded by the PHQ
(Nease et al., 2011). This picture seems to be far different from
what regulatory bodies or physicians expect from outcome and
from what the HDRS or MADRS assess and suggests that a broader
perspective should be considered when assessing outcome. More-
over, real life patients often have comorbid anxious and somatic
symptoms, have excessive negative affect and lack of positive
affect, present with functional impairment in their occupational,
social and family life and report a low quality of life (Demyttenaere
et al., 2010; Demyttenaere et al., 2009; Watson et al., 1988a, 1988b;
De Fruyt and Demyttenaere, 2009). The two standard scales show
some differences here: the HDRS covers a somewhat broader
spectrum of symptoms including anxiety and neurovegetative
(somatic) symptoms while the MADRS is more focused on the
depressive symptomatology but neither scale covers the whole
range of issues/symptoms mentioned above.
Therefore, a more comprehensive assessment of change is
probably warranted and the present study investigates the concor-
dance or divergence between what physicians and patients consider
to be the most important issues in considering cure from depression.
2. Methods
2.1. Ethics statement
This research was performed according to the principlesù of
the Declaration of Helsinki, and written informed consent was
obtained from the participants after explanation of the nature of
the study. The study was approved by the ethics committee of
Hôpital Universitaire Saint-Luc in Woluwe (Brussels).
2.2. Patient recruitment
This is a prospective, non-interventional study conducted in
Belgium between February 2010 and July 2011 in both general and
specialized (psychiatric) practices. According to the study protocol,
150 physicians, speciﬁcally 75 general practitioners (GP) and 75
specialists (SP), were requested to enroll 4 clinically depressed
patients. Any selected physician who declined to participate was
replaced by another physician who previously participated in the
DEsCRIBETM survey (Demyttenaere et al., 2011). At the end of the
enrollment period, 453 patients had been included. Patients, male
or female and older or equal to 18 years, suffering from a novel
episode of clinical depression where the physician decided that
treatment with an antidepressant was indicated and initiated were
eligible for study participation. Patients unable to ﬁll in question-
naires and/or treated for the current episode with an antidepres-
sant for longer than 2 weeks were excluded (N¼27). Therefore,
analyses were performed on 426 patients: 242 patients enrolled
by 61 GPs, 211 patients enrolled by 57 psychiatrists. The mean
number of patients included per physician was 472 (range 1–7);
39% of GPs and 47% of psychiatrists enrolled less than 4 patients.
The study protocol did not interfere with the treatment decisions
of the physician.
2.3. Data collection
Data were collected from both patients and their physicians. At
baseline patient's demographics, medical and psychiatric history,
details on the choice of antidepressant and non-pharmaceutical
treatment were collected and the physician assessed the clinical
status for a given patient with the CGI-S (Clinical Global Impres-
sion of Severity) (Guy, 1976).
What physicians and patients found to be most important in being
cured from depression was assessed with the DEsCRIBETM question-
naire. This questionnaire contains 51 items measuring severity of
depressive, anxious and somatic symptoms, positive affect, functional
impairment and quality of life; the items had been taken from six
validated scales: the Patient Health Questionnaire-Depression subscale
(PHQ-depression); the Hospital Anxiety and Depression Scale-anxiety
subscale (HADS-anxiety); the Patient Health Questionnaire-Somatic
Symptoms severity subscale (PHQ-somatic); the Positive And Negative
Affect Schedule-Positive Affect subscale (PANAS-positive); the Sheehan
Disability Scale (SDS); and the Abbreviated World Health Organiza-
tion QoL scale – psychological and social subscales (WHOQOL-BREF)
(Kroenke et al., 2001; Zigmond and Snaith, 1983; Kroenke et al., 2002;
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Watson et al., 1988; Sheehan et al., 1996;WHO-QOL group, 1998). Each
item is rated on a 5-point Likert scale (where 1¼not important for
being cured from depression and 5¼very important for being cured
from depression).
The clinical status of the patient was assessed with the above
mentioned scales: the patient indeed ﬁlled out the PHQ-depression,
HADS-anxiety, PHQ-somatic, the PANAS-positive mood subscale, the
SDS, and the WHOQOL-BREF at baseline and at 6 months of
treatment (Kroenke et al., 2001; Zigmond and Snaith, 1983;
Kroenke et al., 2002; Watson et al., 1988; Sheehan et al., 1996;
WHO-QOL group, 1998). At 3 months the patient again completed
the DEsCRIBETM questionnaire (in order to test whether the change
in clinical status changed his/her expectations from treatment). The
scales were to be ﬁlled in by the patient in a separate room at the
physician's practice and put in a sealed envelope before handing it
over to the physician in order to avoid any inﬂuencing between
physician and patient. Except for baseline assessments, the patient
had to ﬁll in the questionnaire before seeing the physician.
2.4. Statistical analysis
Results were summarized as mean and standard deviation (SD) for
quantitative variables and scores; counts and proportions (%) were
used for categorical variables. Mean values were compared by one-
way analysis of variance followed by multiple comparisons in case of
several groups. Proportions were compared by the chi-squared test
for contingency tables. The agreement between the physicians and
the patients on the 51 DEsCRIBETM questionnaire items was studied.
First, the means of the 51 DEsCRIBETM items were sorted by dec-
reasing order for the physicians and patients separately. Then, the
agreement on each of the 51 DEsCRIBETM items was assessed taking
into account the matching between the patients and the physicians.
Speciﬁcally, ranks were attributed to each of the 51 DEsCRIBETM items
individually for each patient and for each physician. Based on these
ranks, a pair patient–physician was deﬁned to be in agreement for a
DEsCRIBETM item if they both classiﬁed this item in ﬁrst position
(i.e., ranked in ﬁrst position). The procedure was repeated for each
DEsCRIBE item and for each patient–physician pair. The percentages
of agreement in ﬁrst position of importance in being cured from
depression of the 51 DEsCRIBETM items were sorted by decreasing
order. The entire procedure was repeated for the ranking in last
position of importance in being cured from depression. The above
methodology was repeated according to some physician's and
patient's characteristics.
Results were considered signiﬁcant at the 5% critical level (po
0.05). Calculations were always done on the maximum number of data
available. All statistical calculations were performed using the SAS
(version 9.2 forWindows) and S-PLUS (version 8.1) statistical packages.
3. Results
3.1. Diagnostic and clinical characteristics of the study population
Physicians had been asked to include patients with a diagnosis
of clinical depression ‘where treatment with an antidepressant
was indicated and initiated’. Based on the PHQ-depression scale
scores, 69.8% fulﬁlled criteria for major depression. The mean
scores on the different scales are given in Table 1.
Based on the HADS-anxiety scale 71.1% were probable cases and
20.0% were doubtful cases for an anxiety disorder. Overall, 16.0% of
the patients did not fulﬁll screening/diagnostic criteria for either a
major depressive episode or an anxiety disorder, 12.4% fulﬁlled
diagnostic criteria for a major depressive disorder, 14.5% fulﬁlled
screening criteria for an anxiety disorder, and 57.1% fulﬁlled screen-
ing/diagnostic criteria for both a major depressive episode and an
anxiety disorder. When deﬁning a ‘clinically signiﬁcant functional
impairment’ as a score of at least 4 on the 3 SDS items, 70.7% of the
included patients fulﬁlled this criterion.
The CGI-severity shows that the percentage of moderately, mark-
edly and severely ill was 23.7%, 49.0% and 18.1% respectively. The
relation between CGI-severity and the other scales are illustrated in
Fig. 1. The CGI-severity score was associated with a signiﬁcantly
different score on the PHQ-depression score (po0.0001), the HADS-
anxiety score (p¼0.0007), the global SDS score (po0.0001), the
WHOQOL-BREF psychological (po0.0001) and social subscores
(p¼0.017) but not with the PHQ-somatic score (p¼0.74) and not
with the PANAS-positive score (p¼0.13).
Antidepressants were prescribed to all patients, and 35% of
included patients were already receiving psychotherapeutic treat-
ment (36.1% interpersonal psychotherapy, 34.2% cognitive-behavior
psychotherapy, 7% psychoanalytic psychotherapy, 7% family therapy
and 16.5% other forms of psychotherapy).
3.2. Importance of items for physicians and for patients in deﬁning
cure from depression
3.2.1. Ranking of items being important in deﬁning cure from
depression, as rated by physicians or rated by patients
When comparing the rank order based on the importance of the
different scales for considering the patient cured from depression,
differences were observed between physicians and patients (Table 2).
First, patients overall gave higher scores to each of the scales. Second,
patients ranked quality of life and positive affect higher while
physicians ranked functioning and depressive symptomatology
higher. Somatic symptoms were given the lowest ranking as well
by physicians as by patients.
These differences became even more obvious when looking at the
rank order of the individual items (Table 3a and 3b). Indeed, a more
detailed look at the content of the single items, the physician rated top
10 items comprised 4 items reﬂecting positive affect (how satisﬁed
you are with yourself, how much do you enjoy life, to what extent life
is meaningful, how satisﬁed you are with personal relationships – all
4 from the WHOQOL-BREF) while patient rated top 10 items com-
prised 7 items reﬂecting positive affect (to what extent life is mean-
ingful, how much do you enjoy life, how satisﬁed are you with
yourself, how able are you to concentrate, how strong you feel, how
satisﬁed you are with personal relationships, how active you feel –
5 from the WHOQOL-BREF and 2 from the PANAS-positive). The top
5 items in the ranking by physicians contain 4 depressive symptoms
and 1 impairment item while the top 5 items in the ranking by
patients contain 4 positive affect items and 1 depressive symptom.
The DEsCRIBETM questionnaire was re-administered to the patients at
3 months follow-up (when the clinical status had improved): the top
10 items now comprised 9 positive affect items and only 1 depressive
symptom (in the 10th position) (Table 4).
On the contrary, a high concordance between physicians and
patients was observed on which items are the least important in
Table 1
Demographic characteristics and baseline psychometric scores (n¼426 patients).
Age (years) 46.4713.8
Female gender 65.7%





SDS global score 19.276.81
WHOQOL-BREFpsychological 14.573.88
WHOQOL-BREFsocial relationships 8.3672.54
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the deﬁnition of being cured from depression: the 10 items with
the lowest ranking were all somatic symptoms, as well in the
patient ranking as in the physician ranking.
3.2.2. Variables inﬂuencing the ranking of items being most
important in deﬁning cure from depression
3.2.2.1. Clinical variables. Patients with a ﬁrst depressive episode
had 5 positive affect items in their top 10 most important items for
deﬁning cure from depression while patients with a recurrent
episode had 8 positive affect items in their top 10 (the 5 found in
patients with a ﬁrst depressive episode – to what extent is life
meaningful, how much do you enjoy life, how satisﬁed are you
with yourself, how active are you, how able are you to concentrate
– and 3 additional ones – how satisﬁed are you with relationships,
how interested are you, how strong do you feel).
The content of the patient rated top 10 items was not
inﬂuenced by the diagnostic status (reaching PHQ-depression
criteria for a major depressive episode or not; reaching HADS-
anxiety screening criteria for an anxiety disorder or not), and was
not inﬂuenced by patient gender. In order to further investigate
whether baseline symptom proﬁle inﬂuenced the patient in
considering which factors are most important in deﬁning cure
from depression, a midsplit was performed for each scale and the
ranking was compared in the subgroup of patients with a higher
versus the subgroup of patients with lower than median score.
Overall, the ranking appeared to be mainly independent from
baseline symptom proﬁle: the top 3 were for all subgroups quality
of life, functioning and positive affect and the bottom 3 were
Fig. 1. Scores (mean7SE) on different scales (PHQ-depression, HADS-anxiety, PHQ-somatic, SDS, PANAS-positive, WHOQOL-BREF psychological, WHOQOL social
relationships) according to the CGI-severity.
Table 2
Importance of different scales for assessing cure (physicians versus patients).
Mean (7SD) scores of the six subscales reconstructed from the 51 DEsCRIBETM
items scored by the physician and the patient – by decreasing order.
Physician (n¼453)
Rank Subscale N Mean7SD
1 SDS 424 3.7870.99
2 WHOQOL-BREF 413 3.5970.77
3 PHQ-depression 407 3.5270.88
4 PANAS-positive 410 3.3570.89
5 HADS-anxiety 409 3.1870.96
6 PHQ-somatic 389 2.2470.79
Patient (n¼453)
1 WHOQOL-BREF 413 4.0070.74
2 SDS 424 3.8971.09
3 PANAS-positive 410 3.8670.85
4 PHQ-depression 407 3.6671.00
5 HADS-anxiety 409 3.5471.03
6 PHQ-somatic 389 2.7071.02
Table 3a
Rank order: 10 most important DEsCRIBETM items scored by the physicians (baseline).
Rank Scale item N Mean7SD Item description
1 WHOQOL-BREF 422 4.1071.13 Negative feelings: blue mood,
despair, anxiety, depression
2 PHQ-depressive 418 4.0971.16 Feeling down, depressed or
hopeless
3 PHQ9-depressive 421 4.0071.18 Little interest or pleasure in
doing things
4 SDS 421 3.9971.13 Symptoms disrupted social life/
leisure activities
5 PHQ-depressive 421 3.9971.15 Feeling tired or having little
energy
6 WHOQOL-BREF 423 3.9271.13 How satisﬁed are you with
yourself
7 WHOQOL-BREF 421 3.8771.12 How much are you enjoying life
8 SDS 401 3.7871.30 Symptoms have disrupted your
work
9 WHOQOL-BREF 426 3.7371.20 To what extent life is meaningful
10 WHOQOL-BREF 424 3.7371.13 How satisﬁed are you with your
personal relationships
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always depression, anxiety and somatic symptoms. The only minor
differences were a few subgroups where one scale moved one rank
up or one rank down: in patients with a baseline higher than
median quality of life, or a higher than median positive affect, or a
higher than median anxiety level at baseline or a lower than
median somatic symptom severity, positive affect got the second
highest ranking (instead of the third for the other half of the
patient population or for the entire study group); in patients with
a higher than median functional impairment at baseline, function-
ing got the highest ranking (instead of the other half of the patient
population or for the entire patient population).
3.2.2.2. Physician variables. The content of the patient rated top 10
items was not inﬂuenced by the gender of the physician or by the
professional proﬁle of the physician (psychiatrist or primary care
physician).
3.3. Concordance between physicians and patients on which item is
most important in deﬁning cure
3.3.1. Concordance between physicians and patients: ranking of
items being rated as the most important or the least important in
deﬁning cure from depression by both physicians and patients
Looking at the chance of a particular item to be found the most
important by both physicians and patients, ‘feeling down-depressed-
hopeless’, ‘negative feelings, despair’ and ‘little interest-anhedonia’
were the top 3 having a 34.0%, 33.4% and 28.5% chance of being
ranked as most important by both physicians and patients. Again, the
10 items having the highest chance of being ranked as least important
by both physicians and patients were all somatic symptoms: the
3 items having the highest chance of being ranked as least important
by both physicians and patients were ‘fainting spells’, ‘constipation or
loose bowels or diarrhea’ and ‘dizziness’ (46.6%, 24.6% and 22.4%
respectively).
3.3.2. Variables inﬂuencing concordance between physician and
patients on which item is most important in deﬁning cure
3.3.2.1. Clinical variables. Overall numerically higher physician–
patient concordance percentages on which 3 items are the most
important in deﬁning cure were found in patients with a probable
major depressive episode than in patients without a probable
major depressive episode (based on the PHQ-depression score cut-
off): the percentages of concordance for the top 3 ranked items
were 36.7%, 34.7% and 31.3% for patients fulﬁlling with a probable
major depressive episode, and 33.9%, 28.1% and 28.1% for patients
without a probable major depressive episode.
Even so, overall numerically higher physician–patient concor-
dance percentages on which 3 items are the most important in
deﬁning cure were found in patients with a probable anxiety than
in patients without a probable anxiety disorder (based on the
HADS-anxiety score cut-off): the percentages of concordance for
the top 3 ranked items were 36.4%, 34.9% and 29.1% for patients
with a probable anxiety disorder, and 30.8%, 29.1% and 27.1% for
patients without a probable anxiety disorder).
The concordance percentages on which items are most impor-
tant in deﬁning cure between physicians and patients with a ﬁrst
episode than between physicians and patients with a recurrent
episode of major depression were comparable (top 3 ranked items:
35.8%, 32.4% and 30.0% versus 38.2%, 35.1% and 29.4%).
3.3.2.2. Physician variables. Overall numerically higher physician–
patient concordance percentages on which 3 items are the most
important in deﬁning cure were found between psychiatrists and
patients than between primary care physicians and patients (top
3 ranked items: 40.2%, 40.2% and 33.5% versus 28.6%, 27.4% and 27.4%).
Overall slightly higher physician–patient concordance percen-
tages on which 3 items are the most important in deﬁning cure
were found between female physicians and patients than between
male physicians and patients (top 3 ranked items: 37.9%, 35.4% and
33.3% versus 34.8%, 32.1% and 29.2%).
4. Discussion
Physicians were asked to enroll patients with major depressive
disorder: only 69.8% of the included patients reached the threshold
for ‘probable depression’ on the HADS depression subscale while
71.1% reached the threshold for ‘probable anxiety disorder’ on the
HADS anxiety subscale. While 16% of the patients even did not reach
the threshold neither for ‘probable depression’ nor for ‘probable
anxiety disorder’, 57.1% of the patients reached the threshold for
both ‘probable depression’ and ‘probable anxiety disorder’. These
ﬁgures are very close to those in the larger (N¼3353) naturalistic
FINDER study where the reported percentages were 66.4%, 74.1%,
15.3% and 55.9% respectively and again illustrate that physicians do
not seem to differentiate well between depression and anxiety and
again underscore the highly prevalent comorbidity between anxiety
and depression (Demyttenaere et al., 2009).
When assessing the clinical global impression of severity (CGI)
physicians apparently mainly take into account depressive and
anxious symptoms, functional impairment and the psychological
aspects of quality of life, but not the lack of positive affect nor the
severity of somatic symptoms. This is indeed remarkable since lack
Table 4
Rank order: 10 most important DEsCRIBETM items scored by the patients (at 3 months
follow-up).
Rank Scale item N Mean7SD Item description
1 WHOQOL-BREF 324 4.2170.98 How much do you enjoy life
2 WHOQOL-BREF 322 4.1471.05 How satisﬁed are you with
yourself
3 WHOQOL-BREF 328 4.1371.02 To what extent life is
meaningful
4 WHOQOL-BREF 327 4.0371.04 How able are you to concentrate
5 WHOQOL-BREF 323 3.9971.05 How satisﬁed are you with your
personal relationships
6 PANAS-positive 327 3.947 1.03 Feeling active
7 PANAS-positive 324 3.9271.01 Feeling strong
8 PANAS-positive 325 3.9071.05 Interested
9 PANAS-positive 322 3.9071.06 Enthusiastic
10 PHQ-depression 316 3.8971.25 Feeling down, depressed or
hopeless
Table 3b
Rank order: 10 most important DEsCRIBETM items scored by the patients (baseline).
Rank Scale item N Mean7SD Item description
1 WHOQOL-BREF 426 4.3570.98 To what extent life is meaningful
2 WHOQOL-BREF 421 4.3570.99 How much do you enjoy life
3 WHOQOL-BREF 423 4.2271.11 How satisﬁed are you with
yourself
4 WHOQOL-BREF 422 4.1371.05 How able are you to concentrate
5 WHOQOL-BREF 422 4.0871.31 Negative feelings: blue mood,
despair, anxiety
6 PHQ-depression 421 4.0771.25 Feeling tired or having little
energy
7 PHQ-depression 418 4.0771.31 Feeling down, depressed or
hopeless
8 PANAS-positive 423 4.0571.09 Feeling strong
9 WHOQOL-BREF 424 4.0471.10 How satisﬁed are you with your
personal relationships
10 PANAS-positive 426 4.0471.09 Feeling active
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of positive affect is a core item in the DSM criteria for major
depression. And as mentioned above, it is also remarkable that the
most frequently used scales to assess change in patients with
major depression pay so little attention to items reﬂecting ‘the lack
of interest or pleasure’ (Hamilton, 1960; Montgomery and Asberg,
1979). Somatic symptoms, although highly prevalent in mood and
in anxiety disorders, also do not seem to inﬂuence the CGI.
Important differences were found in what physicians and what
patients consider to be important in relief or cure from depression.
This is already obvious when looking at the ranking of the scales:
physicians emphasize the importance of functioning, quality of life
and depressive symptoms while patients rather emphasize the
importance of quality of life, functioning and positive affect. This
becomes even more obvious when looking at the ranking of
individual items: in the physicians top 10, only 4 items refer to
positive mood while in the patients top 10, 7 items refer to
positive mood. The ﬁnding that restoration of positive mood is
of primary importance for depressed patients is very much in
accordance with the study published by Zimmerman, where the
presence of positive mental health (optimism, vigor, self-conﬁ-
dence) got the highest ranking before feeling like your usual self,
return to your usual level of functioning, feeling in emotional
control, participating and enjoying relationships with family and
friends…and the alleviation of depressive symptoms was ranked
only sixth (Zimmerman et al., 2006). Further research should
investigate whether the patient's ‘broader look’ at outcome also
depends on the causal beliefs patients have on depression: the
public, even when taking antidepressants, continues to hold a
multifactorial causal model of depression with a primary emphasis
on psychosocial issues beyond biogenetic and beyond psychiatric
symptoms (Read et al., 2014a, 2014b; Schomerus et al., 2013). This
could well inﬂuence the way they deﬁne cure from depression.
The present study illustrates that somatic symptoms consis-
tently get the lowest ranking, as well by physicians as by patients:
although physical symptoms are very common in major depres-
sion and in generalized anxiety disorder, and despite the highly
prevalent overlap between depressive, anxious and somatic symp-
toms (in an epidemiological study in a primary care setting,
depression was found in 6.6% but only 1.7% of the patients suffered
from pure depression while 1.1% had comorbid anxiety disorder,
1.6% signiﬁcant somatic symptoms and 2.3% had as well comorbid
anxiety disorder) physicians as well as patients seem to have a
dualistic view and once they the diagnosis of depression is
established, somatic symptoms (associated with depression) no
longer seem to be viewed as important (Löwe et al., 2008).
Diagnostic status (probable case of depression or not, comor-
bidity or not), patient or physician gender, physician specialty (GP
or psychiatrist) did not change the physician's or patient's view on
what is important for being cured from depression. The only
variable that inﬂuenced the ranking was whether patients suffered
from a ﬁrst or a recurrent episode of depression: patients with
recurrent depression even more strongly emphasized positive
affect items as being important to feel cured from depression.
Moreover, when the questionnaire was re-administered to the
patients at 3 months follow-up, positive affect even got a more
important rating: the top 10 items now included 9 positive affect
items. A possible explanation for this ﬁnding could be that clinical
improvement mainly results in a decrease of negative affect
(depressive symptomatology) but to a lower degree in an increase
in positive affect what is than more pronouncedly felt as a lack.
And it could well be that patients with recurrent depression
experienced an ongoing lack of positive affect after their ﬁrst
depressive episode, due to incomplete recovery or due to anti-
depressant side effects. SSRIs are often ﬁrst line antidepressants
and it has indeed been shown that patients reaching remission
with serotonergic agents like ﬂuoxetine, when compared to
healthy controls, report less positive (and less negative) affect
(Opbroek et al., 2002). A qualitative study on the emotional side
effects of SSRIs also described a reduction of positive emotions,
both reduced frequency and reduced intensity, part of what has
been called ‘emotional detachment’ as a side effect of serotonergic
agents: experiencing a restricted range of emotions that usually
are part of everyday life (Price et al., 2009). This was further
illustrated by a large study on the adverse emotional effects in
1829 New Zealanders taking antidepressants where sexual difﬁ-
culties, feeling emotionally numb, feeling not like your usual self
and reduction in positive feelings was reported in over 40% of
patients (Read et al., 2014a, 2014b). And the study also showed
that these emotional effects were not linked to the level of
depression prior to taking antidepressants. Therefore, a perceived
missing of positive emotions could inﬂuence what patients believe
is important in being cured from depression in a subsequent
depressive episode.
When physicians and patients did agree on an item being the
most important for deﬁning cure, feeling down-depressed-hopeless',
‘negative feelings, despair’ and ‘little interest-anhedonia were the
3 items most frequently mentioned. Moreover, higher agreement
percentages was found in patients with a probable depression (com-
pared with no probable depression) and in patients with a probable
anxiety disorder (compared with no probable anxiety disorder)
suggesting that in more severe patients, agreement on which item
is the most important for deﬁning cure increases. On the contrary, the
agreement onwhich items are the least important was highest for the
somatic symptoms. Numerically higher percentages of agreement
were found between psychiatrists and patients than between primary
care physicians and patients and between female physicians and
patients than between male physicians and patients.
In conclusion, physicians and patients seem to differ in their
ranking of what is now most important for cure in depression.
Physicians pay more attention to depressive symptoms and in ass-
essing global severity they mainly take into account depressive and
anxious symptom severity, functional impairment and some aspects
of quality of life but not positive affect and not somatic symptoms
severity. Patients, on the contrary, pay more attention to positive
affect. After 3 months of treatment, patients even pay higher attention
to positive affect as do patients with recurrent depression (compared
to patients with a ﬁrst episode of depression). Agreement uponwhich
symptoms are the most important in deﬁning cure seems to be
higher in cases of a major depressive episode or of an anxiety disorder
than in cases with subthreshold symptomatology.
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